Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
The American Journal of Surgical Pathology|October 19, 2020
A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel ApproachAngela Chou, Mahsa Ahadi, Jennifer Arena, et al.
European Journal of Clinical Investigation|November 2, 2024
Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patientsJosef E Gillson, Sooin Byeon, Angela Chou, et al.
Plos One|October 14, 2015
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I MetabolitesEliška Potůčková, Jaroslav Roh, Miloslav Macháček, et al.
Frontiers in Oncology|March 21, 2020
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant ChemotherapySumit Sahni, Christopher Nahm, Christoph Krisp, et al.
International Journal of Cancer|October 31, 2020
A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinomaSumit Sahni, Advait R Pandya, William J Hadden, et al.
Biochimica Et Biophysica Acta|April 23, 2016
Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT)Elaine M Gutierrez, Nicole A Seebacher, Laila Arzuman, et al.
Oncotarget|April 11, 2015
The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1Wensheng Liu, Fei Yue, Minhua Zheng, et al.
Cancers|July 27, 2022
The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic CancerChristopher B Nahm, John Turchini, Sumit Sahni, et al.
Metallomics : Integrated Biometal Science|June 24, 2016
Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeuticsKyung Chan Park, Leyla Fouani, Patric J Jansson, et al.
European Journal of Pharmacology|April 11, 2024
Novel combinatorial autophagy inhibition therapy for triple negative breast cancersYomna S Abd El-Aziz, Taymin du Toit-Thompson, Matthew J McKay, et al.
Pageof 9